InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by RYAN THOMAS F JR, Director. Director active across 2 companies, notably REPLIGEN CORP. In total, 7 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €330k. History available since 13 May 2021. The latest transaction was disclosed on 1 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
1,000 shares@ US$38.760.0006% mcap10.1% of flowCommon StockSEC:0000899243-22-008827:0
1,285 shares@ US$128.180.0024% mcap41.6% of flowCommon StockSEC:0000899243-21-043040:0
1,285 shares@ US$128.180.0015% mcap46.2% of flowCommon StockSEC:0000899243-21-043040
780 shares@ US$250.500.0028% mcap48.3% of flowCommon StockSEC:0000899243-21-031820:0
780 shares@ US$250.5053.8% of flowCommon StockSEC:0000899243-21-031820
457 shares0Common StockSEC:0000899243-21-019708
457 shares0Common StockSEC:0000899243-21-019708:0
7 of 7 declarations
About RYAN THOMAS F JR
Thomas F. Ryan Jr. serves as a Board Member at Repligen Corp. In this role, he participates in overseeing operations and making strategic decisions. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
